Osteosarcoma and pulmonary metastases: 15-year experience from a single institution

The Australian and New Zealand Journal of Surgery
P M EllisP Stalley


The outcome of management in patients with osteosarcoma and pulmonary metastases at a Sydney teaching hospital was reviewed. A retrospective review was undertaken of all patients diagnosed with osteosarcoma and treated by the Bone and Soft Tissue Unit and the Medical Oncology Department, Royal Prince Alfred Hospital between 1979 and January 1995. Information was collected on demographics, tumour site, tumour histology, primary management including surgery and adjuvant therapy, and the subsequent development and management of pulmonary metastases. A total of 56 patients with localized osteosarcoma was seen. Overall survival and survival following pulmonary metastases was assessed. There were 33 (59%) males and 23 (41%) females, with a median age of 27 years. Survival at 5 years, for patients with non-axial osteosarcoma was 60% (95% CI, 44-77%). Pulmonary metastases without other metastatic disease being apparent, developed in 22 patients, of whom 12 underwent surgical resection. The median disease-free interval of these latter patients was 20 months (95% CI, 8-32 months). Median survival among patients not undergoing surgical resection was 5 months from detection of metastases. Patients undergoing resection of pulmonary metastas...Continue Reading


Sep 1, 1992·Archives of Surgery·K A SkinnerG Rosen
Apr 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P PicciR Casadei
Apr 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R S BenjaminN E Papadopoulos
Apr 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M GoorinM P Link
Aug 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U PastorinoG Ravasi
Jun 19, 1986·The New England Journal of Medicine·M P LinkJ A Kirkpatrick
Jan 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F EilberJ Goodnight
Aug 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N JaffeT Chen
Sep 1, 1971·The Annals of Thoracic Surgery·N MartiniE J Beattie
Dec 1, 1984·Cancer·E J Beattie
Jun 1, 1995·Australian and New Zealand Journal of Medicine·M B JamesonV J Harvey
Nov 1, 1993·American Journal of Surgery·D A SaltzmanA S Leonard

❮ Previous
Next ❯


Mar 16, 2004·Journal of Pediatric Surgery·Wendy T SuMichael P La Quaglia
Jan 16, 2002·The Annals of Thoracic Surgery·G Le GarffP Delaval
Mar 2, 2016·Pediatric Blood & Cancer·Tracy A MarkoLogan G Spector
Nov 8, 2001·Journal of Drug Education·C R CollierU Pitre
Dec 7, 2013·Expert Review of Anticancer Therapy·Nataraj Vijayamurugan, Sameer Bakhshi
Apr 16, 2002·Clinical Orthopaedics and Related Research·Roby C ThompsonChap T Le
May 8, 2001·Cancer Investigation·W S Ferguson, A M Goorin
Aug 8, 2002·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·P BüchlerT Lehnert

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
F DuffaudR Favre
© 2021 Meta ULC. All rights reserved